Effects of Aqueous Fruit Extract of Annona muricata on Testosterone Propionate Induced Benign Prostate Hyperplasia (BPH) in Male Wistar Rats

I.U. Leje *

Department of Medical Laboratory, General Hospital Minna, Niger State, Nigeria.

Wali. U.

Department of Chemical Pathology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.

M.H. Yeldu

Department of Chemical Pathology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.

H.M. Alhassan

Department of Immunology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.

I. Z. Wasagu

Department of Chemical Pathology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.

U. Abubakar

Department of Histopathology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto, Nigeria.

B.H. Abubakar

Drugs and Medical Supply Management, Sokoto State, Nigeria.

H. A. Evuti

Africa Center of Excellence for Mycotoxins and Food Safety, Federal University of Technology, Minna, Niger State, Nigeria.

M. Bello

Department of Chemical Pathology, Specialist Hospital, Sokoto, Sokoto State, Nigeria.

*Author to whom correspondence should be addressed.


Introduction: Benign prostate hyperplasia (BPH) is an age-related non-malignant prostate gland enlargement in men that leads to pain and difficulty voiding urine. The etiology of BPH is still unknown. Studies have been reported on the effects of Annona muricata (soursop) against benign prostatic hyperplasia (BPH) with little documentation.

Aim: This study aimed to determine the effects of aqueous fruit extract of A. muricata on testosterone propionate induced benign prostate hyperplasia (BPH) in male Wistar Rats.

Methodology: The fruits of A. muricata were processed to obtain fruit extract and phytoconstituents. An acute toxicity study was conducted with six doses of A. muricata fruit extract (10, 100, 1000, 1500, 2900 and 5000 mg/kg) to determine the safety and tolerability dose limit. A total of 48 adult male Wistar rats were used for the study. After 2 weeks of acclimatization, the animals were orchimetized. The rats were randomly divided into six groups of eight animals each; group 1 (normal control + sham treated + distilled water); groups 2 (positive control + castrated + TP/day); group 3 (finasteride (3 mg/kg) + castrated + TP/day); group 4 (100 mg/kg AM + castrated + TP/day); group 5 (200 mg/kg AM + castrated + TP/day) and group 6 (400 mg/kg AM + castrated + TP/day) for 42 days. On the 43rd day animals were euthanized, blood and prostate tissue samples were collected for biochemical and histological study.

Results: This study showed that, the extract significantly (p < 0.05) decreased both the prostate weight and testosterone levels in a dose-dependent manner compared to finasteride-treated rats. The effect of the extract on the histology of the prostate had significant recovery and was able to restore the enlarged prostate to near-normal in a dose-dependent manner. A significant (p < 0.05) recovery was observed at a higher dose (400 mg/kg) of the extracts.

Conclusion: The effects of Annona muricata (soursop) against benign prostatic hyperplasia (BPH) showed inhibitory potentials via decreased prostate weight, prostate specific antigen, and testosterone levels in a dose-dependent manner. At a high dose (400 mg/kg) body weight of rats had significant recovery (p < 0.05) restoring prostatic histoarchitecture to near-normal. This study suggests that Annona muricata fruit may be considered a treatment option for benign prostatic hyperplasia in men.

Keywords: A. muricata, benign prostate hyperplasia (BPH), testosterone propionate

How to Cite

Leje, I.U., Wali. U., M.H. Yeldu, H.M. Alhassan, I. Z. Wasagu, U. Abubakar, B.H. Abubakar, H. A. Evuti, and M. Bello. 2024. “Effects of Aqueous Fruit Extract of Annona Muricata on Testosterone Propionate Induced Benign Prostate Hyperplasia (BPH) in Male Wistar Rats”. Asian Journal of Research in Biochemistry 14 (4):72-83. https://doi.org/10.9734/ajrb/2024/v14i4295.


Download data is not yet available.


Jadallah S, Li Y, Chu LW. Prevalence of BPH and lower urinary tract symptoms in West Africans. Prost Cancer and Prostate Disease. 2012;15: 170–176.

Madersbacher S, Sampson N, Culig Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontology. 2019;65(5):458-464.

Wang W, Guo Y, Zhang D, Tian Y, Zhang X. The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys. Scientific Reports. 2015;5(1):13546.

Obeagu EI, Awil MA, Obeagu GU. Prostate cancer: Prevention, risk factors, pathophysiology. Journal of Biomedical Innovation. 2023;12(2):437-442.

Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. The Lancet. 2003; 361(9351):60–62.

Ejike CECC, Eze KC. Prevalence of symptoms of benign Prostatic hyperplasia in Umudike and its relationship with measures of obesity. Asia Pac Journal of Clinical Nutrition. 2015;7(1):1–8.

Kim JH, Park KM, Lee JA. Herbal medicine for benign prostatic hyperplasia: A protocol for a systematic review of controlled trials. Medicine (Baltimore). 2019;98(1): 14023.

Geavlete P, Multescu R, Geavlete B. Serenoa repens extract in the treatment of benign prostatic hyperplasia. Therapeutic and Advance Urology. 2011;3:193–198.

Doku DA. Antiproliferative activity of aqueous leaf extract of Annona muricata (linn.) on rat prostate, BPH-1 cells and some target genes. A thesis submitted in partial fulfilment of the requirements for the Degree of Master of Science (Chemical Patholgy) In the Department of Molecular Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; 2016.

Kalu WO, Okafor PN, Ijeh II. Effect of kolaviron, a biflavanoid complex from Garcinia kola on some biochemical parameters in experimentally induced benign prostatic hyperplasic rats. Biomedical and Pharmacotherapy. 2016; 83:1436–1443.

Sharma M, Chadha R, Dhingra N. Phytotherapeutic agents for benign prostatic hyperplasia: An overview. Mini Review Medical Chemistry. 2017;17(14): 1346–1363.

Coria-Téllez AV, Montalvo-Gónzalez E, Yahia EM. Obledo-Vázquez EN. Annona muricata: A comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity. Arabian Journal of Chemistry. 2018;11:662- 691.

Moghadamtousi SZ, Fadaeinasab M, Nikzad S, Mohan G, Ali HM, Kadir H. Annona muricata (Annonaceae): A review of its traditional uses, isolated acetogenins and biological activities. International Journal of Molecular Sciences. 2015;16: 15625-15658.

Rady I, Bloch MB, Chamcheu RCN, Banang Mbeumi S, Anwar MR, Mohamed H, Babatunde AS, Kuiate JR, Noubissi FK, El Sayed KA. Anticancer Properties of Graviola (A. Muricata): A comprehensive mechanistic review. Oxidative Medicine and Cell Longevity. 2018;1-3.

Harbone JB. Phytochemical methods, Second edition, Chapman and Hall Ltd, London. 1976:52-55.

Trease H, Evans G. Mexican medicinal plants. Journal of Ethnopharmacy and Pharmacogenetics. 1989;13:222-230.

Sofowora A, Harbone J. Screening for bioactive agents. Institute of Medicinal Plants and Traditional Medicine in Africa, 2nd edition. Spectrum Books Limited: Ibadan, Nigeria. 1993;134-156.

Obisike UA, Boisa N, Nwachuku EO, Nduka N. Antiproliferative potentials of zingiberofficinale in testosterone induced prostate hyperplastic albino wister rats. International Research Journal of Oncology. 2020;3(2): 20-30.

Lorkes D. A new approach to practical acute toxicity testing. Architectural Toxicology. 1983;54:275-287.

OECD. OECD guidelines for the testing of chemicals, OECD publishing; Paris, France: Test No. 425: Acute Oral tyoxicity: Up-and-Down Procedure. 2005;1-15.

Khoo LM, Kow ASF, Maulidiani M, Lee MT, Tan CP, Shaari KK, Tham CL, Abas FA. Hematological, biochemical, histopathological and 1h-nmr metabolomics appplication in acute toxicity evaluation of Clinacanthus nutsans water leaf extract. Molecules. 2018;23:2172.

Faul F, Erdfelder E, Lang AG, Buchner AG. Power 3: A flexible statistical power analysis program for the social, behavioral and biomedical sciences. Behavioral Resources Method. 2007;39:175-191.

Cohen, J. statistical power analysis for behavioral sciences. 2nd ed. Hillsdale, NJA: Lawrence Erlbaum; 1988.

Shin I, Lee M, Jung D. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia. Food Chemistry and Toxicology. 2012;50:884–888.

Ogbu PN, Ugota EO, Onwuka RU, Ogbu IM, Aloke C. Effect of acetogenin fraction of Annona muricata leaves on antioxidant status and some indices of benign prostatic hyperplasia in rats. Redox Report. 2020;25(1):80-86.

Kumar AH, Clover AJ. Intraperitoneal co-administration of low dose urethane with xylazine and ketamine for extended duration of surgical anesthesia in rats. Laboratory Animal Research. 2015;31:174-179.

Ishola IO, Anunobi CC, Tijani KH, Afolayan O, Udokwu VU. Potential of telmisartan in the treatment of benign prostatic hyperplasia. Fundamental of Clinical Pharmacology. 2021;31(6):643-51.

Kiernan JA. Histological and histochemical methods: Theory and practice. 4th Edn; 2008.

Yu ZJ, Yan HL, Xu FH, Chao HC, Deng LH, Xu XD, Zeng, T. Efficacy and side effects of drugs commonly used for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. Frontiers in Pharmacology. 2020;11:658.

Chikezie CI. On the effect of methanol leaf extract of Annona muricata on antioxidant enzymes in dihydrotestosterone estradiol valerate induced benign prostatic hyperplasia in male albino rats. 2023; 7-2.

Siti NZ, Wasim SMQ, Syahida M, Norazlan MM, Halimatul SMN, Ahmed M. Assessing the acute toxicological effects of A. muricata leaf ethanol extract on rats: Biochemical, histopathological and metabolomics analyses. 2023;11(8):688.

Minciullo PL, Inferrera A, Navarra, M. Oxidative stress in benign prostatic hyperplasia: A systematic review. Urologia Internationalis. 2015;94:249–254.

Padma P, Chansouria J, Khosa R. Effect of alcohol extract of Annona muricata on cold immobilization stress induced tissue lipid peroxidation. Phytotherapy and Research. 2017;11:326–327.

Roduan MRM, Hamid RA, Kqueen CY. Cytotoxicity, antitumor promoting and antioxidant activities of Annona muricata In vitro. Journal of Herb and Medicine. 2019; 15(2):100219.

Opara PO, Enemor VHA, Eneh FU, Emengaha FC. Blood glucose-lowering potentials of a. muricata leaf extract in alloxan induced diabetes rats. European Journal of Biology and Biotechnology. 2021;2:106-113.

Choi H, Jung Y, Park J. Cinnamomi cortex (Cinnamomum verum) suppresses testosterone-induced benign prostatic hyperplasia by regulating 5α-reductase. Science and Research. 2016;6: 31906.

Kapoor A. Benign prostatic hyperplasia management in the primary care setting. Canadian Journal of Urology. 2021;19(1): 10–17.

Morcos MA, Afifi NM. Effect of doxazocin on experimentally induced prostatic hyperplasia in adult male albino rats: A histological and immunohistochemical study. Egypt Journal of Histology. 2011; 34(4):870–882.

Shin I, Lee M, Jung D. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia. Food Chemistry and Toxicology. 2012;50:884–888.

Patience NO, Evelyn O. Ugota R, Onwuka U, Ikechukwu MO, Chinyere A. Effect of acetogenin fraction of Annonamuricataleaves on antioxidant status and some indices of benign prostatic hyperplasia in rats. Redox Report. 2020;25(1):80-86.

Sing B, Ram SN, Pandey VB. Studies on anti-inflammatory activity of taraxasterol acetate from Echinopsechinatus in rats and mice. Phytotherapy and Research. 2021;5:103–106.

Mulia K, Winarcahyo SW, Krisanti E. Practical isolation of Bullatacin from Annona muricata leaves extract using an open column chromatography Technique. Advance Master of Research. 2018;789:545–550.

Ibukun OE, Ogunlade LO, Oladipo GO. Annona muricata (Soursop) mitigated testicular toxicity and prostatic impairment in testosterone-propionate-induced BPH in Male Rats. Achievers Journal of Scientific Research. 2023;5(2):01-11.

Hwangbo H, Kwon DH, Choi EO, Kim MY, Ahn KI, Ji SY, Choi YH. Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats. Nutrition Research and Practice. 2018;12(5):378-386.

Izumi K, Mizokami A, Lin WJ, Lai KP, Chang C. Androgen receptor roles in the development of benign prostate hyperplasia. The American Journal of Pathology. 2013;182(6):1942-1949.

Cannarella R, Condorelli RA, Barbagallo F, La Vignera S, Calogero AE. Endocrinology of the aging prostate: current concepts. Frontiers in Endocrinology. 2021;5(5):40-78.

Uchenna AF, Obioma EN, Chinedu IB, Ejiofor DC. Anti-hyperlipidemic effect of methanol seed kernel extract of Mangifera indica on wistar rat model. Asian Journal of Biochemistry, Genetics and Molecular Biology. 2023;13(4):11–14.


Moharib SA, Adly RS. Hypoglycemic and hepatoprotective activities of coriander (Coriandrum sativum) Extract in Streptozocin Induced Diabetic Rats. Journal of Advances in Biology & Biotechnology. 2024;27(2):15–38. Available:https://doi.org/10.9734/jabb/2024/v27i2696

Adaramoye OA, Okiti OO, Farombi EO. Dried fruit extract from Xylopia aethiopica (Annonaceae) protects Wistar albino rats from adverse effects of whole body radiation. Experimental and Toxicologic Pathology. 2011 Nov 1;63(7-8):635-43.

Okwu DE. Phytochemicals and vitamin content of indigenous species of South Eastern Nigeria. Journal of Sustain Agriculture Environment. 2004; 6:30-34.